Today we announced U.S. Food and Drug Administration – FDA clearance of ABANZA’s Washercap™ Fixation System for the Anterior Cruciate Ligament Reconstruction.
Washercap™ is the first soft tissue graft fixation device designed to allow surgeons to execute a fixation non-dependent on patient bone quality with precision and full control.
«The FDA clearance of Washercap™ is exciting because it offers surgeons a highly trusted solution for soft tissue graft fixation, especially valuable for young and female patients, and revision procedures. Washercap™ helps to secure a stronger and more rigid tibial fixation, which will support a better #ACL surgery outcome», Juan Abascal, Chief Operating Officer at ABANZA.
